Press Releases about Gilead Sciences
![](https://mms.businesswire.com/media/20240426676086/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240425746971/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240408350262/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240401185946_biotech-sector-nears-breakout-will-it-outperform-i.jpg)
![](https://mms.businesswire.com/media/20240327502740/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240328734624/en/2082732/5/Xilio_Full_CLR_Logo_CMYK_%5Bwith_registered_mark%5D.jpg)
![](https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png)
![](https://mms.businesswire.com/media/20240311327601/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240306036015/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240305598604/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240306606452/en/2055933/22/Logo_Merus_CMYK_Blue_1000x280.jpg)
![](https://mms.businesswire.com/media/20240304530607/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240304716860/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240227849231/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240226441430/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240223287683/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20240220712986/en/778437/5/GCP_Primarylarge_1.jpg)
Gilead Sciences to Present at Upcoming Investor Conferences
February 20, 2024
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240214075553_analysts-see-over-50-gains-in-these-2-mid-cap-biot.jpg)
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240211034242/en/2030601/5/Logo_CymaBay-Therapeutics-Oct18-rgb-color.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240208075998/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240206319017/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240206426528/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240201926422/en/778437/5/GCP_Primarylarge_1.jpg)
Ted Love, MD, Joins Gilead Sciences’ Board of Directors
February 01, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240121113292/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Arcus Biosciences
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.